Bone marrow-derived mesenchymal stromal cells support rat pancreatic islet survival and insulin secretory function in vitro

Cytotherapy

Volumn 13, Issue 1, 2011, Pages 19-29

  Jung, Eun Jung ^a   Kim, Song Cheol ^b   Wee, Yu Mee ^a   Kim, Yang Hee ^a   Choi, Monica Young ^a   Jeong, Seong Hee ^a   Lee, Jiyeon ^a   Lim, Dong Gyun ^b   Han, Duck Jong ^b  

^a Asan Medical Center   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Contact culture; Insulin secretory function; Mesenchymal stromal cell; Pancreatic islet; Vascular endothelial growth factor

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; BONE MARROW; BONE MARROW DERIVED MESENCHYMAL STROMAL CELL; CELL CONTACT; CELL CULTURE; CELL PROTECTION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCAGON RELEASE; IN VITRO STUDY; INSULIN RELEASE; MESENCHYMAL STEM CELL; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT;

EID: 78650372121     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2010.518608     Document Type: Article

References (31)

1. Miki A, Narushima M, Okitsu T, Takeno Y, Soto-Gutierrez A, Rivas-Carrillo JD, et al. Maintenance of mouse, rat, and pig pancreatic islet functions by coculture with human isletderived fi broblasts. Cell Transplant. 2006;15:325-34.
2. Chao KC, Chao KF, Chen CF, Liu SH. A novel human stem cell coculture system that maintains the survival and function of culture islet-like cell clusters. Cell Transplant. 2008;17: 657-64.
3. Piemonti L, Leone BE, Nano R, Saccani A, Monti P, Maffi P, et al. Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes. 2002;51:55-65.
4. Cross SE, Richards SK, Clark A, Benest AV, Bates DO, Mathieson PW, et al. Vascular endothelial growth factor as a survival factor for human islets: effect of immunosuppressive drugs. Diabetologia. 2007;50:1423-32.
5. Jiang H, Zhu H, Chen X, Peng Y, Wang J, Liu F, et al. TIMP-1 transgenic mice recover from diabetes induced by multiple low-dose streptozotocin. Diabetes. 2007;56:49-56.
6. Kim DH, Yoo KH, Yim YS, Choi J, Lee SH, Jung HL, et al. Cotransplanted bone marrow derived mesenchymal stem cells (MSC) enhanced engraftment of hematopoietic stem cells in a MSC-dose dependent manner in NOD/SCID mice. J Korean Med Sci. 2006;21:1000-4.
7. Brohlin M, Mahay D, Novikov LN, Terenghi G, Wiberg M, Shawcross SG, Novikova LN. Characterisation of human mesenchymal stem cells following differentiation into Schwann cell-like cells. Neurosci Res. 2009;64:41-9.
8. Popp FC, Renner P, Eggenhofer E, Slowik P, Geissler EK, Piso P, et al. Mesenchymal stem cells as immunomodulators after liver transplantation. Liver Transpl. 2009;15:1192-8.
9. Bacigalupo A, Valle M, Podest M, Pitto A, Zocchi E, De Flora A, et al. T-cell suppression mediated by mesenchymal stem cells is defi cient in patients with severe aplastic anemia. Exp Hematol. 2005;33:819-27.
10. Rasmusson I, Ringdén O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res. 2005;305:33-41.
11. Komori M, Tsuji S, Tsujii M, Murata H, Iijima H, Yasumaru M, et al. Effi ciency of bone marrow-derived cells in regeneration of the stomach after induction of ethanol-induced ulcers in rats. J Gastroenterol. 2005;40:591-9.
12. Wu Y, Chen L, Scott PG, Tredget EE. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells. 2007;25:2648-59.
13. Imanishi Y, Saito A, Komoda H, Kitagawa-Sakakida S, Miyagawa S, Kondoh H, et al. Allogenic mesenchymal stem cell transplantation has a therapeutic effect in acute myocardial infarction in rats. J Mol Cell Cardiol . 2008;44:662-71.
14. Liu K, Chi L, Guo L, Liu X, Luo C, Zhang S, He G. The interactions between brain microvascular endothelial cells and mesenchymal stem cells under hypoxic conditions. Microvasc Res . 2008;75:59-67.
15. Murray HE, Paget MB, Bailey CJ, Downing R. Sustained insulin secretory response in human islets co-cultured with pancreatic duct-derived epithelial cells within a rotational cell culture system. Diabetologia. 2009;52:477-85.
16. Lee J, Han DJ, Kim SC. In vitro differentiation of human adipose tissue-derived stem cells into cells with pancreatic phenotype by regenerating pancreas extract. Biochem Biophys Res Commun. 2008;375:547-51.
17. Choi KS, Shin JS, Lee JJ, Kim YS, Kim SB, Kim CW. In vitro trans-differentiation of rat mesenchymal cells into insulinproducing cells by rat pancreatic extract. Biochem Biophys Res Commun. 2005;330:1299-305.
18. Lee RH, Seo MJ, Reger RL, Spees JL, Pulin AA, Olson SD, Prockop DJ. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci USA. 2006;103:17438-43.
19. Timper K, Seboek D, Eberhardt M, Linscheid P, Christ-Crain M, Keller U, et al. Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun. 2006;341:1135-40.
20. Luo L, Badiavas E, Luo JZ, Maizel A. Allogeneic bone marrow supports human islet beta cell survival and function over six months. Biochem Biophys Res Commun. 2007;361: 859-64.
21. Zhang B, Lu Y, Campbell-Thompson M, Spencer T, Wasserfall C, Atkinson M, Song S. Alpha1-antitrypsin protects beta-cells from apoptosis. Diabetes. 2007;56:1316-23.
22. Han X, Sun Y, Scott S, Bleich D. Tissue inhibitor of metalloproteinase- 1 prevents cytokine-mediated dysfunction and cytotoxicity in pancreatic islets and beta-cells. Diabetes. 2001;50:1047-55.
23. Tran VV, Chen G, Newgard CB, Hohmeier HE. Discrete and complementary mechanisms of protection of beta-cells against cytokine-induced and oxidative damage achieved by bcl-2 overexpression and a cytokine selection strategy. Diabetes. 2003;52:1423-32.
24. Kang MK, Yoon YE, Yang JY, Kwon KB, Park JW, Jhee EC. Protective effect of retinoic acid on interleukin-1 beta-induced cytotoxicity of pancreatic beta-cells. Mech Ageing Dev. 2004;125:483-90.
25. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009;29:313-26.
26. Zhou YP, Madjidi A, Wilson ME, Nothhelfer DA, Johnson JH, Palma JF, et al. Matrix metalloproteinases contribute to insulin insuffi ciency in Zucker diabetic fatty rats. Diabetes. 2005;54:2612-9.
27. Figliuzzi M, Cornolti R, Perico N, Rota C, Morigi M, Remuzzi G, et al. Bone marrow-derived mesenchymal stem cells improve islet graft function in diabetic rats. Transplant Proc. 2009;41:1797-800.
28. Johansson U, Rasmusson I, Niclou SP, Forslund N, Gustavsson L, Nilsson B, et al. Formation of composite endothelial cell - mesenchymal stem cell islets: a novel approach to promote islet revascularization. Diabetes. 2008;57:2393-401.
29. Jabs N, Franklin I, Brenner MB, Gromada J, Ferrara N, Wollheim CB, Lammert E. Reduced insulin secretion and content in VEGF-a defi cient mouse pancreatic islets. Exp Clin Endocrinol Diabetes. 2008;116(Suppl 1):S46-9.
30. Zhang N, Richter A, Suriawinata J, Harbaran S, Altomonte J, Cong L, et al. Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. Diabetes. 2004;53:963-70.
31. Lai Y, Schneider D, Kidszun A, Hauck-Schmalenberger I, Breier G, Brandhorst D, et al. Vascular endothelial growth factor increases functional beta-cell mass by improvement of angiogenesis of isolated human and murine pancreatic islets. Transplantation. 2005;79:1530-6.